Since the onset of the COVID-19 pandemic in March, the supply and demand for N95 have been largely stabilized; however, there are still dramatic discrepancies in the allotted number of masks across different states. Why is that after a year of battling the virus, warehouses in Texas are drowning in!-->…
Read More...
COVID-19 has shown the world that there is no clear barrier between viruses affecting animals and people. Mink have been reported to get infected with SARS-CoV-2 and die in large numbers in at least a half-dozen countries around the world. They are often found in crowded, caged conditions on farms,!-->…
Read More...
The National Institutes of Health has awarded UC San Diego $1.3 million to develop a tool for monitoring COVID-19 exposure. According to UC San Diego nano engineers, the lightweight test strip will contain a sensor for detecting virus molecules that appear in a person’s breath or saliva. The sensor!-->…
Read More...
COVID-19 does not mutate as readily as other viruses that cause flu, hepatitis, or AIDS, but its stability has been severely overestimated. Recent studies suggest that there are a few people who have recovered from COVID-19 but happened to get re-infected with the mutant strains. Both vaccines!-->…
Read More...
According to Tim Spector, a professor of genetic epidemiology at King’s College London, there has been an increasing number of COVID-19 positive patients who complain of tongue discoloration as well as a range of mouth ulcers. Approximately 35% of COVID-19 patients experience non-traditional!-->…
Read More...
British researchers from a biotechnology company, Synairgen, have completed a Phase 2 trial with interferon beta-1a that is typically used to decrease inflammation and reduce multiple sclerosis. The drug was administered to 48 patients using a nebulizer and after 2 weeks, patients who had received!-->…
Read More...
Monoclonal antibodies are lab-made drugs that are meant to mimic natural antibodies to SARS-CoV-2. It is considered a recommended treatment for those who are at a higher risk of contracting COVID-19, including those over the age of 65. According to Dr. William Fales, medical director f the Michigan!-->…
Read More...
As Moderna is set to deliver at least 600 million doses of vaccine in 2021, there are looming questions over how long will vaccine immunity last. Unfortunately, clinical trials are not effective in predicting the precise longevity of the immunity. However, according to Moderna CEO Stéphane Bancel,!-->…
Read More...
The researchers at Washington University of St. Louis are recruiting 1,100 people to see if a popular anti-depressant drug, Luvox, might keep someone from becoming severely ill with COVID-19. A smaller study in November indicated that modern anti-depressants that work primarily by selectively!-->…
Read More...
The common symptom of losing the sense of smell and taste among COVID-19 positive people is not as simple as it seems. According to investigators at the Glenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases at the University of Texas Health Science Centre at San Antonio, SARS-CoV-2!-->…
Read More...
A new coronavirus variant, first discovered in the UK, is slowly, but steadily making its way around the globe. A new study, conducted by the Imperial College London, suggests that the higher transmissibility of the variant is likely to also put those under 20 years of age at risk. Early analysis!-->…
Read More...
Extensive political polarization has gotten health officials struggling to invoke trust among people as the United States prepares for the arrival of the COVID-19 vaccine. It has been estimated that 60 to 70 percent of the US population will need to get vaccinated to substantially decrease!-->…
Read More...
As the world holds its breath and waits for the start of Pfizer’s COVID-19 vaccine distribution, there is a looming question about the apparent exclusion of pregnant women in vaccine trials. Pregnant women have been found to be at an increased risk of contracting severe forms of COVID-19. According!-->…
Read More...
The arrival of the highly anticipated COVID-19 vaccines from Pfizer and Moderna raises questions about how well their effectiveness compares to natural immunity. Natural immunity is greatly dependent on the amount of virus to which the person was exposed, which, in turn, determines the “quality” of!-->…
Read More...